Selected research
Industry Growth & Trends
Global Digital COPD Management Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Digital COPD Management market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Digital COPD Management is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Digital COPD Management is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Digital COPD Management is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Digital COPD Management market include Teva Digital Health, AstraZeneca Digital Health, GSK Digital Health, Boehringer Ingelheim Digital Health, Huma Therapeutics, Biofourmis, Kaia Health, Ada Health and Current Health, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Digital COPD Management market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Digital COPD Management market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Digital COPD Management market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Digital COPD Management.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Digital COPD Management market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Digital COPD Management Market by Company
Teva Digital Health
AstraZeneca Digital Health
GSK Digital Health
Boehringer Ingelheim Digital Health
Huma Therapeutics
Biofourmis
Kaia Health
Ada Health
Current Health
Wellinks
Sensviv
ResMed Inc
Philips Respironics
Propeller Health
Digital COPD Management Segment by Type
Symptom Monitoring
Lung Function Management
Acute Exacerbation Prediction
Medication Adherence Management
Others
Digital COPD Management Segment by Application
Hospital Respiratory Department Management
Home Health Self-Management
Insurance-Based Health Management
Telemedicine
Digital COPD Management Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Digital COPD Management market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Digital COPD Management and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Digital COPD Management.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Digital COPD Management companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Symptom Monitoring
- Lung Function Management
- Acute Exacerbation Prediction
- Medication Adherence Management
- Others
Applications
- Hospital Respiratory Department Management
- Home Health Self-Management
- Insurance-Based Health Management
- Telemedicine
Companies covered
- Teva Digital Health
- AstraZeneca Digital Health
- GSK Digital Health
- Boehringer Ingelheim Digital Health
- Huma Therapeutics
- Biofourmis
- Kaia Health
- Ada Health
- Current Health
- Wellinks
- Sensviv
- ResMed Inc
- Philips Respironics
- Propeller Health
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Digital COPD Management Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Digital COPD Management Market Size by Region (2021-2032)
- 1.4.1 Global Digital COPD Management Market Size by Region (2021-2026)
- 1.4.2 Global Digital COPD Management Market Size by Region (2027-2032)
- 1.5 Key Regions Digital COPD Management Market Size (2021-2032)
- 1.5.1 North America Digital COPD Management Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Digital COPD Management Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Digital COPD Management Market Size Growth Rate (2021-2032)
- 1.5.4 South America Digital COPD Management Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Digital COPD Management Market Size Growth Rate (2021-2032)
2 Digital COPD Management Market by Type
- 2.1 Type Introduction
- 2.1.1 Symptom Monitoring
- 2.1.2 Lung Function Management
- 2.1.3 Acute Exacerbation Prediction
- 2.1.4 Medication Adherence Management
- 2.1.5 Others
- 2.2 Global Digital COPD Management Market Size by Type
- 2.2.1 Global Digital COPD Management Market Size Overview by Type (2021-2032)
- 2.2.2 Global Digital COPD Management Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Digital COPD Management Market Size Forecasted by Type (2027-2032)
- 2.3 Global Digital COPD Management Market Size by Regions
- 2.3.1 North America Digital COPD Management Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Digital COPD Management Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Digital COPD Management Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Digital COPD Management Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Digital COPD Management Market Size Breakdown by Type (2021-2026)
3 Digital COPD Management Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospital Respiratory Department Management
- 3.1.2 Home Health Self-Management
- 3.1.3 Insurance-Based Health Management
- 3.1.4 Telemedicine
- 3.2 Global Digital COPD Management Market Size by Application
- 3.2.1 Global Digital COPD Management Market Size Overview by Application (2021-2032)
- 3.2.2 Global Digital COPD Management Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Digital COPD Management Market Size Forecasted by Application (2027-2032)
- 3.3 Global Digital COPD Management Market Size by Regions
- 3.3.1 North America Digital COPD Management Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Digital COPD Management Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Digital COPD Management Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Digital COPD Management Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Digital COPD Management Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Digital COPD Management Industry Trends
- 4.2 Digital COPD Management Industry Drivers
- 4.3 Digital COPD Management Industry Opportunities and Challenges
- 4.4 Digital COPD Management Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Digital COPD Management Revenue (2021-2026)
- 5.2 Global Digital COPD Management Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Digital COPD Management Key Company Headquarters & Area Served
- 5.4 Global Digital COPD Management Company, Product Type & Application
- 5.5 Global Digital COPD Management Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Digital COPD Management Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Digital COPD Management Players Market Share by Revenue in 2025
- 5.6.3 2025 Digital COPD Management Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Teva Digital Health
- 6.1.1 Teva Digital Health Company Information
- 6.1.2 Teva Digital Health Business Overview
- 6.1.3 Teva Digital Health Digital COPD Management Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Teva Digital Health Digital COPD Management Product Portfolio
- 6.1.5 Teva Digital Health Recent Developments
- 6.2 AstraZeneca Digital Health
- 6.2.1 AstraZeneca Digital Health Company Information
- 6.2.2 AstraZeneca Digital Health Business Overview
- 6.2.3 AstraZeneca Digital Health Digital COPD Management Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 AstraZeneca Digital Health Digital COPD Management Product Portfolio
- 6.2.5 AstraZeneca Digital Health Recent Developments
- 6.3 GSK Digital Health
- 6.3.1 GSK Digital Health Company Information
- 6.3.2 GSK Digital Health Business Overview
- 6.3.3 GSK Digital Health Digital COPD Management Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 GSK Digital Health Digital COPD Management Product Portfolio
- 6.3.5 GSK Digital Health Recent Developments
- 6.4 Boehringer Ingelheim Digital Health
- 6.4.1 Boehringer Ingelheim Digital Health Company Information
- 6.4.2 Boehringer Ingelheim Digital Health Business Overview
- 6.4.3 Boehringer Ingelheim Digital Health Digital COPD Management Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Boehringer Ingelheim Digital Health Digital COPD Management Product Portfolio
- 6.4.5 Boehringer Ingelheim Digital Health Recent Developments
- 6.5 Huma Therapeutics
- 6.5.1 Huma Therapeutics Company Information
- 6.5.2 Huma Therapeutics Business Overview
- 6.5.3 Huma Therapeutics Digital COPD Management Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Huma Therapeutics Digital COPD Management Product Portfolio
- 6.5.5 Huma Therapeutics Recent Developments
- 6.6 Biofourmis
- 6.6.1 Biofourmis Company Information
- 6.6.2 Biofourmis Business Overview
- 6.6.3 Biofourmis Digital COPD Management Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Biofourmis Digital COPD Management Product Portfolio
- 6.6.5 Biofourmis Recent Developments
- 6.7 Kaia Health
- 6.7.1 Kaia Health Company Information
- 6.7.2 Kaia Health Business Overview
- 6.7.3 Kaia Health Digital COPD Management Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Kaia Health Digital COPD Management Product Portfolio
- 6.7.5 Kaia Health Recent Developments
- 6.8 Ada Health
- 6.8.1 Ada Health Company Information
- 6.8.2 Ada Health Business Overview
- 6.8.3 Ada Health Digital COPD Management Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Ada Health Digital COPD Management Product Portfolio
- 6.8.5 Ada Health Recent Developments
- 6.9 Current Health
- 6.9.1 Current Health Company Information
- 6.9.2 Current Health Business Overview
- 6.9.3 Current Health Digital COPD Management Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Current Health Digital COPD Management Product Portfolio
- 6.9.5 Current Health Recent Developments
- 6.10 Wellinks
- 6.10.1 Wellinks Company Information
- 6.10.2 Wellinks Business Overview
- 6.10.3 Wellinks Digital COPD Management Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Wellinks Digital COPD Management Product Portfolio
- 6.10.5 Wellinks Recent Developments
- 6.11 Sensviv
- 6.11.1 Sensviv Company Information
- 6.11.2 Sensviv Business Overview
- 6.11.3 Sensviv Digital COPD Management Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Sensviv Digital COPD Management Product Portfolio
- 6.11.5 Sensviv Recent Developments
- 6.12 ResMed Inc
- 6.12.1 ResMed Inc Company Information
- 6.12.2 ResMed Inc Business Overview
- 6.12.3 ResMed Inc Digital COPD Management Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 ResMed Inc Digital COPD Management Product Portfolio
- 6.12.5 ResMed Inc Recent Developments
- 6.13 Philips Respironics
- 6.13.1 Philips Respironics Company Information
- 6.13.2 Philips Respironics Business Overview
- 6.13.3 Philips Respironics Digital COPD Management Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Philips Respironics Digital COPD Management Product Portfolio
- 6.13.5 Philips Respironics Recent Developments
- 6.14 Propeller Health
- 6.14.1 Propeller Health Company Information
- 6.14.2 Propeller Health Business Overview
- 6.14.3 Propeller Health Digital COPD Management Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Propeller Health Digital COPD Management Product Portfolio
- 6.14.5 Propeller Health Recent Developments
7 North America
- 7.1 North America Digital COPD Management Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Digital COPD Management Market Size by Country (2021-2026)
- 7.3 North America Digital COPD Management Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Digital COPD Management Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Digital COPD Management Market Size by Country (2021-2026)
- 8.3 Europe Digital COPD Management Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Digital COPD Management Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Digital COPD Management Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Digital COPD Management Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Digital COPD Management Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Digital COPD Management Market Size by Country (2021-2026)
- 10.3 South America Digital COPD Management Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Digital COPD Management Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Digital COPD Management Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Digital COPD Management Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst